PRA Health Sciences

PRA Health Sciences
Public
Traded as
Industry Pharmaceuticals & Biotechnology
Founded 1976 (1976)
Charlottesville, Virginia, U.S.
Headquarters Raleigh, North Carolina, U.S.
Area served
 Worldwide
Key people
 Colin Shannon (President and CEO)
Revenue
  • Increase US$ 1.948 billion (2017)[1]
  • Increase US$ 1.580 billion (2016) [1]
Number of employees
 15,800[1]
Website prahs.com

PRA Health Sciences is a contract research organization (CRO) with headquarters in Raleigh, North Carolina that was founded in 1982.[2] In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 while maintaining control of it.[1]

In August 2017 the company acquired Conshohocken-based health and analytics company Symphony Health for USD $530 million.[3] The company's 2017 revenue was just under USD $2 billion.[1]

References

  1. 1 2 3 4 5 "PRA 10-K For the fiscal year ended December 31, 2017". PRA Health Sciences via SEC Edgar. 2018-02-02. See SEC Edgar index page for PRA for updates
  2. ↑ "PRA Health Sciences becomes latest big CRO to launch IPO". CenterWatch News Online. 13 November 2014.
  3. ↑ Liu, Angus (August 8, 2017). "PRA Health Sciences makes $530M Symphony buy, reports 16% revenue growth in Q2". FierceBiotech.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.